Exclusive: ARCH-backed exercise-in-a-pill startup quietly laid off half its staff, ‘fully pivoted’ in October

Jason Mast

Editor

In December 2019, a tiny decade-old California startup known as Cardero Therapeutics announced a new name — Epirium Bio — a new direction and $85 million …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: ARCH-backed exercise-in-a-pill startup quietly laid off half its staff, ‘fully pivoted’ in October

Jason Mast

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ex­clu­sive: ARCH-backed ex­er­cise-in-a-pill start­up qui­et­ly laid off half its staff, ‘ful­ly piv­ot­ed’ in Oc­to­ber

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: ARCH-backed exercise-in-a-pill startup quietly laid off half its staff, ‘fully pivoted’ in October